 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              The Initial Public Offering (IPO) of Ammana Bio Pharma Limited has evoked poor response from investors with the issue failing to receive subscription even on the closing day of the issue. The company came out with an IPO at a price band of Rs.12 to Rs.14 through 100% Book Building process.
As on 05 April 2007 at 1700 hrs the issue has received subscription of 0.17 times. Out of the total issue of 16800000 equity shares, the company has received subscription for just 2910500 equity shares. The company has received subscription for 1895500 equity shares at Cut-off price.
The issue failed to receive even a single application for shares from Qualified Institutional Buyers (QIBs). Out of the reservation of 2520000 equity shares for Non Institutional Investors the company received subscription for 761500 equity shares resulting in subscription of 0.3022 times. Out of 5880000 equity shares the Retail Individual Investors (RIIs) portion received subscription for 2149000 equity shares resulting in subscription of 0.3655 times.